or Try an Advanced Search...

    Technical Analysis for ATX - Amplia Therapeutics Limited

    Grade Last Price % Change Price Change
    D 0.062 0.00% 0.000
    ATX closed unchanged on Thursday, May 2, 2024, on 82 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ATX trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Down Weakness 0.00%
    Calm After Storm Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Volume Surge Other 1.64%
    Wide Bands Range Expansion 1.64%
    Calm After Storm Range Contraction -4.62%
    Narrow Range Bar Range Contraction -4.62%
    Older End-of-Day Signals for ATX ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low 6 days ago
    2x Volume Pace 6 days ago
    Down 1% 6 days ago
    1.5x Volume Pace 6 days ago
    Up 2% 6 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ATX Chart by TradingView
    Basic chart:

    Profile

    Amplia Therapeutics Limited, formerly Innate Immunotherapeutics Limited, is a pharmaceutical company. The Company is engaged in research and development of immune-oncology drugs and chemotherapies to address serious unmet needs in fibrotic tumors. The Company is focused on advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis, particularly focused on pancreatic and ovarian cancer. Its initial clinical development pipeline comprises of two novel orally available small molecule FAK inhibitors: AMP945 (FAK-only) and AMP886 (FAK/FLT3/VEGFR3). FAK also plays a significant role in a number of chronic diseases, such as idiopathic pulmonary fibrosis (IPF).
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Health Medicine Pharmaceutical Disease Cancer Diseases Drugs Oncology Tumor Chemotherapy Tumors Chronic Disease Fibrosis Ovarian Cancer Chronic Diseases Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis

    Is ATX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.115
    52 Week Low 0.055
    Average Volume 118,024
    200-Day Moving Average 0.081
    50-Day Moving Average 0.075
    20-Day Moving Average 0.071
    10-Day Moving Average 0.064
    Average True Range 0.004
    RSI (14) 31.97
    ADX 31.07
    +DI 16.835
    -DI 46.465
    Chandelier Exit (Long, 3 ATRs) 0.075
    Chandelier Exit (Short, 3 ATRs) 0.068
    Upper Bollinger Bands 0.087
    Lower Bollinger Band 0.055
    Percent B (%b) 0.21
    BandWidth 44.225
    MACD Line -0.004
    MACD Signal Line -0.003
    MACD Histogram -0.0011
    Fundamentals Value
    Market Cap 6.67 Million
    Num Shares 108 Million
    EPS -0.05
    Price-to-Earnings (P/E) Ratio -1.32
    Price-to-Sales 0.00
    Price-to-Book 2.69
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.065
    Resistance 3 (R3) 0.065 0.063 0.065
    Resistance 2 (R2) 0.063 0.063 0.064 0.064
    Resistance 1 (R1) 0.063 0.062 0.063 0.063 0.064
    Pivot Point 0.061 0.061 0.062 0.062 0.061
    Support 1 (S1) 0.061 0.061 0.061 0.061 0.060
    Support 2 (S2) 0.059 0.060 0.060 0.060
    Support 3 (S3) 0.059 0.059 0.060
    Support 4 (S4) 0.059